Clinical Trials
67 trialsTissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
National Institutes of Health Clinical Center (CC)
BASECAMP-1
A2 Biotherapeutics Inc.
DP-04
AstraZeneca
Clinical Application of PET Imaging Targeting MSLN in Malignant Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
DESCENT-1
A2 Biotherapeutics Inc.
National Cancer Institute "Cancer Moonshot Biobank"
National Cancer Institute (NCI)
LONGEVITI
University of Alberta
iCaRe2
University of Nebraska
CER
Cancer Support Community, Research and Training Institute, Philadelphia
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
National Institutes of Health Clinical Center (CC)
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer
SWOG Cancer Research Network
TraveraRTGx
Travera Inc
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
ASAP
Avera McKennan Hospital & University Health Center
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Wake Forest University Health Sciences
PRO-ACTIVE
Fondazione del Piemonte per l'Oncologia
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Carevive Systems, Inc.
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
National Cancer Institute (NCI)
EXoPERT EMERALD Clinical Study
EXoPERT
CAMPERR
Adela, Inc
SCORE
Natera, Inc.
CCANED-CIPHER
Dysplasia Diagnostics Limited
LIBERATE
University Health Network, Toronto
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
Alaunos Therapeutics
Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs
Alaunos Therapeutics
PRIORITY
Institut Bergonié
START
Lyell Immunopharma, Inc.
Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques
Yonsei University
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
PREFER
Labcorp Corporation of America Holdings, Inc
INSPIRE
Singlera Genomics Inc.
MOHCCN-O
University Health Network, Toronto
ROOT
Taproot Health
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
QUANTUM
VitaMed Research LLC
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Sanguine Biosciences
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Beijing Friendship Hospital
Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus Biosimilars
Biologics & Biosimilars Collective Intelligence Consortium
Establishment of a Tumor Bank for Blood Samples
Medical University of Vienna
Establishment of a Tumor Bank for Tissue Samples
Medical University of Vienna
Guangzhou Women's Health Cohort Study (GWHCS)
Guangzhou Women and Children's Medical Center
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
Wuhan Ammunition Life-tech Co., Ltd
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Exact Sciences Corporation
Taiwan Cancer Moonshot Project
Academia Sinica, Taiwan
Validation of the Russian and Kazakh Versions of the Beck Depression Inventory and Beck Anxiety Inventory
Kazakh Medical University of Continuing Education
PASSION
Assistance Publique - Hôpitaux de Paris
SPACE2
Weprom
ADOPT
University of Dundee
PSM
Oslo University Hospital